Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 06, 2015 16:15 ET | Source: Neoleukin Therapeutics, Inc.

Aquinox Pharmaceuticals Announces Positive Results From Secondary Endpoints From Phase 2 LEADERSHIP Trial in BPS/IC and Reports Second Quarter 2015 Financial Results

VANCOUVER, British Columbia, Aug. 6, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
August 05, 2015 09:15 ET | Source: Neoleukin Therapeutics, Inc.

Aquinox Pharmaceuticals to Present at the Canaccord Genuity 35th Annual Growth Conference

VANCOUVER, British Columbia, Aug. 5, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
July 28, 2015 09:15 ET | Source: Neoleukin Therapeutics, Inc.

Aquinox Pharmaceuticals to Provide Update on Secondary Endpoints From Phase 2 LEADERSHIP Trial in BPS/IC and Report Second Quarter Financial Results on August 6, 2015

VANCOUVER, British Columbia, July 28, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
July 09, 2015 08:30 ET | Source: Neoleukin Therapeutics, Inc.

Aquinox Pharmaceuticals Announces Results From FLAGSHIP Trial With AQX-1125 in Chronic Obstructive Pulmonary Disease Patients With Frequent Exacerbations

VANCOUVER, British Columbia, July 9, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
June 25, 2015 08:30 ET | Source: Neoleukin Therapeutics, Inc.

Aquinox Pharmaceuticals Announces Results From LEADERSHIP Trial With AQX-1125 in Patients With Bladder Pain Syndrome/Interstitial Cystitis

VANCOUVER, British Columbia, June 25, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
May 26, 2015 09:15 ET | Source: Neoleukin Therapeutics, Inc.

Aquinox Pharmaceuticals to Present at 2015 Jefferies Global Healthcare Conference

VANCOUVER, British Columbia, May 26, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
May 12, 2015 09:15 ET | Source: Neoleukin Therapeutics, Inc.

Aquinox Pharmaceuticals Announces First Quarter 2015 Financial Results

VANCOUVER, British Columbia, May 12, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
May 04, 2015 09:15 ET | Source: Neoleukin Therapeutics, Inc.

Aquinox Pharmaceuticals Completes Enrollment in the Phase 2 KINSHIP Trial of AQX-1125 in Atopic Dermatitis

VANCOUVER, British Columbia, May 4, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
April 27, 2015 09:15 ET | Source: Neoleukin Therapeutics, Inc.

Aquinox Pharmaceuticals to Present at 2015 Bloom Burton & Co. Healthcare Investor Conference

VANCOUVER, British Columbia, April 27, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
April 07, 2015 09:15 ET | Source: Neoleukin Therapeutics, Inc.

Aquinox Pharmaceuticals to Present at 14th Annual Needham Healthcare Conference

VANCOUVER, British Columbia, April 7, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...